Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Anti-Inflammatory Drugs Market?

The market size of anti-inflammatory drugs has seen a swift expansion in recent years, escalating from $136.86 billion in 2024 to an estimated $152.08 billion in 2025 with a compound annual growth rate (CAGR) of 11.1%. The factors responsible for this growth in the historical timeline include an aging population, a high incidence of chronic inflammatory diseases, expanded over-the-counter accessibility, a surge in knowledge regarding pain management, and the growth of healthcare infrastructure.

What Growth Rate Is Forecasted for the Anti-Inflammatory Drugs Market by 2029?

The market size for anti-inflammatory drugs is forecasted to experience a swift expansion in the coming years. By 2029, the market is predicted to reach a value of $228.83 billion, with a compound annual growth rate (CAGR) of 10.8%. This projected growth within the predicted period can be credited to a rise in autoimmune disease prevalence, the growing demand for personalized medication, an increase in the elderly population, government initiatives in support, and a heightened preference for targeted and topical therapies. Key trends expected within this period encompass development in biologic drugs, a trend towards biologics and biosimilars, prescriptions via telemedicine, the use of AI in drug discovery, research, and development into new anti-inflammatory mechanisms, along with innovations in targeted anti-inflammatory treatments.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24465&type=smp

Which Key Companies Are Shaping the Future of the Anti-Inflammatory Drugs Market?

Major companies operating in the anti-inflammatory drugs market are Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Gilead Sciences Inc., Amgen Inc., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Inc., UCB S.A., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Dr. Reddy’s Laboratories, Cipla Limited, Cadila Pharmaceuticals, Samsung Bioepis, Lupin Limited

Which Factors Are Driving Demand in the Anti-Inflammatory Drugs Industry?

The increasing incidence of arthritis is anticipated to fuel the expansion of the anti-inflammatory drugs market in the future. Arthritis is characterized by inflammation in one or more joints, leading to discomfort, swelling, and stiffness that can intensify with age. The escalation in arthritis cases can be primarily attributed to the aging population, as the natural degradation of joints amplifies with age, increasing the probability of arthritis. Anti-inflammatory medications aid in arthritis management by mitigating joint inflammation and pain, enabling patients to retain better mobility and carry out daily tasks more comfortably, thereby enhancing their overall well-being. For example, the Office for Health Improvement and Disparities, a government department in the UK, reported in March 2023 that in 2022, 17.6% of people aged 16 and over informed of having a long-term musculoskeletal (MSK) issue, like arthritis or an ongoing back or joint problem. This figure saw an increase from 17.0% in 2021. Consequently, the increasing incidence of arthritis is driving the expansion of the anti-inflammatory drugs market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=24465&type=smp

How Is the Anti-Inflammatory Drugs Market Segmented by Several Divisions?

The anti-inflammatory drugs market covered in this report is segmented –

1) By Drug Class: Steroids, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Biologics And Biosimilars, Other Drug Classes

2) By Route of Administration: Parenteral, Oral, Topical, Inhalation

3) By Applications: Autoimmune Diseases, Respiratory Diseases, Other Diseases

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Steroids: Corticosteroids, Mineralocorticoids

2) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Non-Selective Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Selective Cyclooxygenase-2 (COX-2) Inhibitors

3) By Biologics And Biosimilars: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin (IL) Inhibitors, Janus Kinase (JAK) Inhibitors, Other Biologics And Biosimilars

4) By Other Drug Classes: Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants, Antihistamines

What are the Emerging Market Trends Driving the Growth of the Anti-Inflammatory Drugs Industry?

Major firms in the anti-inflammatory drugs market are concentrating their efforts on creating innovative formulations such as a topical solution to provide targeted therapy and enhance patient adherence. Topical solutions are medicines in liquid form that are applied directly onto the skin or the affected region. They assist anti-inflammatory medications by locally delivering the active compounds, decreasing inflammation in the particular area while diminishing overall systemic side effects. Illustrating this point, in December 2022, Lupin Limited, a pharmaceutical company based in India, launched the approved generic version of PENNSAID (Diclofenac Sodium Topical Solution, 2% w/w) from Horizon Pharma Therapeutics in the U.S. This was done to broaden its collection of U.S. generics and increase the availability of cost-effective anti-inflammatory treatments. This nonsteroidal anti-inflammatory drug is employed to alleviate pain caused by knee osteoarthritis, offering local relief through application on skin, whilst reducing the systemic side effects commonly experienced with oral NSAIDs.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/anti-inflammatory-drugs-global-market-report

Which Regions Are Driving Growth in the Anti-Inflammatory Drugs Market?

North America was the largest region in the anti-inflammatory drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-inflammatory drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24465

This Report Delivers Insight On:

1. How big is the anti-inflammatory drugs market, and how is it changing globally?

2. Who are the major companies in the anti-inflammatory drugs market, and how are they performing?

3. What are the key opportunities and risks in the anti-inflammatory drugs market right now?

4. Which products or customer segments are growing the most in the anti-inflammatory drugs market?

5. What factors are helping or slowing down the growth of the anti-inflammatory drugs market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model